1.Remnant Pacemaker Lead Tips after Lead Extractions in Pacemaker Infections.
Daehoon KIM ; Yong Soo BAEK ; Misol LEE ; Jae Sun UHM ; Hui Nam PAK ; Moon Hyoung LEE ; Boyoung JOUNG
Korean Circulation Journal 2016;46(4):569-573
Complete hardware removal is recommended in the case of patients with cardiovascular implantable electronic device (CIED) infections. However, the complete extraction of chronically implanted leads is not always achieved. The outcomes and optimal management of CIED infections with retained material after lead extractions have not been elucidated. In this case report, we present five patients with CIED infections with remnant lead tips even after lead extractions. Two patients had localized pocket infections, and were managed with antibiotics for a period of more than two weeks. The other three patients had infective endocarditis, and were managed with antibiotics for a period of more than four weeks. In one patient, the lead tip migrated to the right pulmonary artery, but did not produce any symptoms or complications. Only one of five patients experienced a resurgence of an infection.
Anti-Bacterial Agents
;
Device Removal
;
Endocarditis
;
Humans
;
Pacemaker, Artificial
;
Pulmonary Artery
2.Fatty liver associated with metabolic derangement in patients with chronic kidney disease: A controlled attenuation parameter study.
Chang Yun YOON ; Misol LEE ; Seung Up KIM ; Hyunsun LIM ; Tae Ik CHANG ; Youn Kyung KEE ; Seung Gyu HAN ; In Mee HAN ; Young Eun KWON ; Kyoung Sook PARK ; Mi Jung LEE ; Jung Tak PARK ; Seung Hyeok HAN ; Sang Hoon AHN ; Shin Wook KANG ; Tae Hyun YOO
Kidney Research and Clinical Practice 2017;36(1):48-57
BACKGROUND: Hepatic steatosis measured with controlled attenuation parameter (CAP) using transient elastography predicts metabolic syndrome in the general population. We investigated whether CAP predicted metabolic syndrome in chronic kidney disease patients. METHODS: CAP was measured with transient elastography in 465 predialysis chronic kidney disease patients (mean age, 57.5 years). RESULTS: The median CAP value was 239 (202–274) dB/m. In 195 (41.9%) patients with metabolic syndrome, diabetes mellitus was more prevalent (105 [53.8%] vs. 71 [26.3%], P < 0.001), with significantly increased urine albumin-to-creatinine ratio (184 [38–706] vs. 56 [16–408] mg/g Cr, P = 0.003), high sensitivity C-reactive protein levels (5.4 [1.4–28.2] vs. 1.7 [0.6–9.9] mg/L, P < 0.001), and CAP (248 [210–302] vs. 226 [196–259] dB/m, P < 0.001). In multiple linear regression analysis, CAP was independently related to body mass index (β = 0.742, P < 0.001), triglyceride levels (β = 2.034, P < 0.001), estimated glomerular filtration rate (β = 0.316, P = 0.001), serum albumin (β = 1.386, P < 0.001), alanine aminotransferase (β = 0.064, P = 0.029), and total bilirubin (β = −0.881, P = 0.009). In multiple logistic regression analysis, increased CAP was independently associated with increased metabolic syndrome risk (per 10 dB/m increase; odds ratio, 1.093; 95% confidence interval, 1.009–1.183; P = 0.029) even after adjusting for multiple confounding factors. CONCLUSION: Increased CAP measured with transient elastography significantly correlated with and could predict increased metabolic syndrome risk in chronic kidney disease patients.
Alanine Transaminase
;
Bilirubin
;
Body Mass Index
;
C-Reactive Protein
;
Diabetes Mellitus
;
Elasticity Imaging Techniques
;
Fatty Liver*
;
Glomerular Filtration Rate
;
Humans
;
Linear Models
;
Logistic Models
;
Odds Ratio
;
Renal Insufficiency, Chronic*
;
Serum Albumin
;
Triglycerides
3.Body mass index is inversely associated with mortality in patients with acute kidney injury undergoing continuous renal replacement therapy.
Hyoungnae KIM ; Joohwan KIM ; Changhwan SEO ; Misol LEE ; Min Uk CHA ; Su Young JUNG ; Jong Hyun JHEE ; Seohyun PARK ; Hae Ryong YUN ; Youn Kyung KEE ; Chang Yun YOON ; Hyung Jung OH ; Jung Tak PARK ; Tae Ik CHANG ; Tae Hyun YOO ; Shin Wook KANG ; Seung Hyeok HAN
Kidney Research and Clinical Practice 2017;36(1):39-47
BACKGROUND: Many epidemiologic studies have reported on the controversial concept of the obesity paradox. The presence of acute kidney injury (AKI) can accelerate energy-consuming processes, particularly in patients requiring continuous renal replacement therapy (CRRT). Thus, we aimed to investigate whether obesity can provide a survival benefit in this highly catabolic condition. METHODS: We conducted an observational study in 212 patients who had undergone CRRT owing to various causes of AKI between 2010 and 2014. The study end point was defined as death that occurred within 30 days after the initiation of CRRT. RESULTS: Patients were categorized into three groups according to tertiles of body mass index (BMI). During ≥30 days after the initiation of CRRT, 39 patients (57.4%) in the highest tertile died, as compared with 58 patients (78.4%) in the lowest tertile (P = 0.02). In a multivariable analysis adjusted for cofounding factors, the highest tertile of BMI was significantly associated with a decreased risk of death (hazard ratio [HR], 0.57; 95% confidence interval [CI], 0.37–0.87; P = 0.01). This significant association remained unaltered for 60-day (HR, 0.64; 95% CI, 0.43–0.94; P = 0.03) and 90-day mortality (HR, 0.66; 95% CI, 0.44–0.97; P = 0.03). CONCLUSION: This study showed that a higher BMI confer a survival benefit over a lower BMI in AKI patients undergoing CRRT.
Acute Kidney Injury*
;
Body Mass Index*
;
Epidemiologic Studies
;
Humans
;
Mortality*
;
Obesity
;
Observational Study
;
Renal Replacement Therapy*